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Portaca\ al Shunt for Type 11 Hypll"lipidemia 1 
Thomas E. Starz!. Lawrence KllCp .• _10 Richard Weil. III 
Amelioration of Type 2 hyperlipidemia by completely diverting portacaval 
shunt was first reported in 1973 (Starzl et al). Since then, 5 additional 
patients have been similarly treated by us and others have been treated 
elsewhere. The compiled first cases have been published (Starzl, Putnam 
and Koep 1978) and, doubtless more will be added by Stein in his review 
later today. My remarks today will be confined to a brief description of 
6 patients treated at the University of Colorado from one month to 6 li2 
years ago. 
Case Material 
All 6 patients had Type 2 hyperlipidemia. Familial studies <"-.• 'ays KKIp-~e 
obtained to determine the probability of the homozygous or h('f_erozygo'.is 
state. The conclusions were compatible with tissue culture ar.Jlysis of 
cholesterol synthesis. Five children had homozygous disease. A 52 year 
old man was heterozygous. 
The 6 patients had been followed in established lipid centers during [,lOg 
periods of study and treatment. The referring physicians were H. P. Ch ,,:C 
of Denver (Case 1), D.W. Bilheimer, J.L. Goldstein, and N.S. Brown of Dallas 
(Case 2), N.B. Javitt of New York and J. Rey of Paris (Case i), E.H. Ahrens 
of New York (Cases 4 and 6), and E.J. Schaefer of Bethesda (Case 5). By 
collaborating with authorities in the field, three objectives were met. 
First, the patients were assured accurate diagnosis as well a~ trials with 
the most advanced methods of uon-surgical treatment including (Cases < and 
5) plasma exchange. Second, sophisticated studies of cholesterol anC;3r 
bile acid metabolism at the referring institution were obtained berore and 
after the brief (one to two weeks) admission to Col.lrado General eosp!~al 
for surgical care. Finally, the aftercare and concLusions about the ,tin-
ical results were the purview of objective observers who were not notable 
proponents of a surgical approach. Data and photographs were T'rovidE''' by 
the referring physicians, of whom some have published separate invest~Sa­
tions. 
The preoperative cardiovascular status of the patients was variable. Ll 
ariciitirm to aortic stenosis. (gradient 56 =Hg) Patient 1 h::!c h.:!::! ::! !!'.:,:)-
cardial infarction 1 1/2 months before portacaval shunt, leading to a large 
left ventircular aneurysm. Patient 6 had had a myocardial infarction treated 
5 years earlier with a triple coronary artery bypass; the diseased residual 
vessels were not susceptible to further reconstruction. Patients 2 and 5 
had continuous angina pectoris and multiple coronary artery les~onsI u~d in 
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addition Patient 2 had a large intraluminal plaque occupying two thirds of 
the ascending aortic lumen. Patient 3 had large asymptomatic intraaortic 
plaques in the chest and abdomen. Patient 4 had aortic stenosis with a gra-
dient of 35 mmHg during a cardiac output of 5 l/min. Tendinocutaneous xan-
thomas were present in each case, and were exceptionally prominent in Patients 
1, 2 and 5. The average serum cholesterol concen~rations before portacaval 
shunt are shown in Table 1. These values usually were obtained during a low 
cholesterol diet and in spite of medicinal therapy. All 6 patients had nor-
mal liver function tests. 
Results 
There was no operative mortality nor any surgical complications. Five of 
the 6 patients are still alive. The first patient died suddenly 18 1/2 
months after operation, probably from a cardiac arrhythmia. 
Effect of serum cholesterol 
A fall in serum cholesterol concentrations was already identifiable within a 
few postoperative weeks, and by August and September 1979, were at the levels 
shown in Table 1. In some patients, slow declines continued for a year or 
longer after operation. Late secondary rises of serum cholesterol concentra-
tions were not seen. Low d~nsity lipoprotein (LDL) falls paralleled those of 
cholesterol. 
Effect on xanthomas 
In Cases 1-5, there was a remarkable involution of the tendinocutaneous 
xanthomas which was evident within a month or two by a softening of these 
lesions and by the development of redundant overlying skin folds. Complete 
disappearance in the oldest cases required one to 3 years. Patient 6 who 
had minimal xanthomas has been followed for too short a time to see a defi-
nite change. 
Cardiovascular disease 
During the first 16 months postoperatively, the aortic valve gradient in 
Patient I" fell from 56 to 10 mnillg, but she had a large ventricular aneurysm 
and residual stenoses of the right, left main, and circumflex coronary ar-
teries. An error was made at that time by deciding against coronary revas-
cularization since the patient's death 2 1/2 months later was apparently 
due to a cardiac arrhythmia. 
Patient 2 had myocardial ischemia and persistent angina. Ultimately, she 
underwent aortic and mitral valve replacement and double coronary artery 
bypass. She is now 5 years postoperative and asymptomatic under treatment 
with a low cholesterol diet, cholestyramine, and Atromid-S. Patients 3-6 
have not had follow up angiograpnic studies. 
The effect on the liver 
Standard liver function tests have not been perturbed except for minor and 
generally persistent increases in alkaline phosphatase and serum transamin-
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logical 
Patient 3 has had slightly elevated blood ammonia concentrations. 
the patients have had encephalopathy nor have they experienced pyscho-
disturbances. 
Patient 1 had a liver biopsy at the time of and 6 months after portacaval 
shunt. The liver was examined again after her death at 18 1/2 months. The 
findings in the second 2 specimens included hepatocyte atrophy, depletion of 
rough endoplasmic reticulum, deglycogenation, and fatty infiltration. These 
same hepatic changes have been documented after complete portal diversion in 
all species so far studied including rats, dogs, swine, subhuman primates 
and humans (Putnam, Porter and Starzl, 1976): 
Physique 
The growth and development of the children have been uninterrupted or in 
some instances somewhat more rapid than preoperatively. Growth spurts were 
not seen of the magnitude of ~hose following portacaval shunt tor glycogen 
storage disease. 
Discussion 
Most of the reported patients with. Type 2 hyperlipidemia treated with portal 
diversion have had reductions in serum cholesterol although the degree has 
been variable (Starzl, Putnam and Koep 1977). Thrombosis of the portacaval 
shunt with restoration by col laterals of hepatopetal splanchnic flow has 
been a well documented cause of failure. 
The antilipidemic effect of portacaval shunt has not been satisfactorily 
examined. It does not depend upon the prior existence of high serum lipids. 
A fall in serum cholesterol and often in triglycerides and phospholipids can 
be produced with this procedure in normal rats, dogs, pigs and nonkeys as 
reviewed by Starzl, Putnam and Koep (1978). The penalty is damage to the 
liver which is striking by histopathological criteria but which is more subtle 
as measured by'liver function. The eventual consequence in pigs, dogs, and 
monkeys is hepatic encephalopathy and death within a few months. I .. rats 
and humans, portacaval shunt is compatible with long survival inspite of the 
fact that the morphologic changes produced in the liver are no less severe. 
The antilipidemic effect is probably due in part to reduced hepatic choles-
terol synthesis by the altered liver (Starzl, Putnam and Koep 1978), but 
other mechanisms may playa significant role. 
Appreciation of the potential hepatic and cerebral complications of porta-
caval shunt dictated our ear.l.ier policy of treatin2, onl)' patD:Dr:-:~s K:KI~:RKt:h !;.O!!l.O-
zygous disease who were refractory to medical therapy and who seemed to have 
a grim short term prognosis. The fact that our first 5 patients were chil-
dren may have contributed to their resistance to encephalopathy. The fate 
of our heterozygous adult patient will be a matter of great interest in 
assessing broader applicability of portal diversion for the treatment of 
hyperlipidemia. 
The hope that vascular disease might be controlled or even regress has been 
supported by observations such as those in Case 1. However, a complete 
reversal of vascular lesions which possess a fibrotic component is often 
not a realistic hope even though there is dramatic resolution of the visible 
peripheral xanthomas and objective evidence that the same can occur within 
the heart valves and blood vessels. An aggressive surgical approach such 
as that taken in Case 2 might have saved our first patient. The combination 
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of coronary revascularization plus port~caval shunt used in Cases 2 and 6 
deserves further trials. 
Table 1. Patients with type II hyperlipidemia treated with portal diversion 
at the University of Colorado Health Sciences Center. 
No. Age/Sex Date Shunt Cholesterol (mg%) Clinical State 
Before After* 
1 12 F 3/1/73 770 290 (38%) Died after 18 1/2 months 
2 7 F 10/4/74 1000 400 (40%) Excellent 
3 8 M 8/5/75 1000 510 (51%) Excellent 
4 5 M 12/14/78 800 515 (64%) Excellent 
5 14 M 6/19/79 880 600 (68%) Excellent 
6 52 M 8/7/79 575 390 (68%) Too soon to evaluate 
*Last values for living patients in late August and early September, 1979. 
Percentages are those of preoperative values. 
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